New patent for NOVO drug SAXENDA

Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-two patents protecting…

The post New patent for NOVO drug SAXENDA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.